Gemtuzumab ozogamicin-associated sinusoi
✍
June M. McKoy; Cara Angelotta; Charles L. Bennett; Martin S. Tallman; Martha Wad
📂
Article
📅
2007
🏛
Elsevier Science
🌐
English
⚖ 128 KB
Gemtuzumab ozogamicin (GO) was approved for marketing in 2000 by the United States Food and Drug Administration (FDA) for older patients with relapsed acute myeloid leukemia (AML). Four months later, 14 phase II clinical trial participants who received novel GO-containing combination chemotherapy re